Login to Your Account



NewCo News

OvaScience Aims to Reshape IVF Using Egg Precursor Cells

By Marie Powers
Staff Writer

Friday, April 6, 2012
Privately held OvaScience has burst onto the infertility scene in a big way, raising $43 million since its founding in 2011, including a $37 million Series B round that closed this week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription